Question 26014 — health

Summary

Mr. Jean-Pierre Vigier draws the attention of the Minister of Solidarity and Health to the announcement by the company Medtronic to end the production of its implantable insulin pumps. By 2020, Medtronic has announced that it will no longer market implantable insulin pumps, also called miniMed (MIP), in France. However, some diabetics have no other choice than to use this device which is the only one that can regulate severe hyperglycemic and/or hypoglycemic episodes as well as the multiple complications associated with them. The production stoppage currently concerns 299 patients in France, the majority of whom could not do without this pump without serious complications developing. However, and even if the company has reiterated its desire to guarantee the availability of consumables necessary for the proper functioning of the pumps installed until the end of their use by patients, no decision has been made regarding their replacement. This is why he asks what concrete means will be put in place, by June 2020, to allow diabetics who benefit from an implantable insulin pump to be able to continue living without the need to resort to unsuitable treatments with no certain effectiveness.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.